PROSION

A radically new therapeutic approach that aims to improve the quality of life of cancer patients and beyond: PROSION Therapeutics is a biotech & drug development company with a proprietary “LEGO-like” platform, aiming to address highly unmet medical needs by unlocking undruggable protein targets. Starting off in oncology, our mission is to develop new drugs against hard-to-treat diseases with the vision to directly benefit patients’ survival and overall quality of life. As of 2022, PROSION is backed by the European Commission through their prestigious EIC Accelerator.